Delivery Order SPE2DB22D3501-SPE2DB25FVX13
- Not listed
- The Defense Logistics Agency awarded a $1,905.89 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Dextroamphetamine ER 10 mg capsules (100 count). The award was competitively procured with no set-aside designation and requires ultimate completion by July 15, 2025. AmerisourceBergen will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Dextroamphetamine ER 15 mg capsules (90-count units) with a ceiling value of $4,078.51. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dextroamphetamine ER 10 mg capsules (100-count units) with a ceiling value of $2,586.96. The contract was competitively awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $2,468.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dextroamphetamine ER 15 mg capsules (90-count supply) on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-competitive delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract will be performed at the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Dextroamphetamine SR Caps 15mg, a controlled-release central nervous system stimulant medication. This firm fixed-price delivery order, valued at $6,915.33, represents a competitive award with no set-aside designation and is scheduled for completion by August 26, 2025. The contract will be performed at AmerisourceBergen's corporate office location...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Dextroamphetamine SR Capsules 15mg, with a ceiling value of $7,992.76. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, indicating the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dextroamphetamine ER 10 mg capsules (100-count units) valued at $1,020.65. This firm fixed-price delivery order, which is expected to be completed by July 28, 2025, carries no set-aside designation and was competitively awarded. The product will be sourced from the contractor's Conshohocken, Pennsylvania facility. This award represents a routine pharmaceutical delivery under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,635.56 firm fixed-price delivery order on August 29, 2025, for Dextroamphetamine ER 15 mg capsules (90-count units), with completion targeted for September 2, 2025. This non-set-aside award was issued to the vendor's Corporate Office located in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,966.33 for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on August 7, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Dextroamphetamine ER 10 mg capsules (90-count) valued at $2,804.48. This competitively awarded, firm fixed-price delivery order was issued on June 18, 2025, with an ultimate completion date of June 20, 2025, and will be performed at the vendor's corporate office location in Conshohocken, PA. The contract carries no set-aside...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FVX13Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Dextroamphetamine ER 15 mg capsules (90-count units) with a contract value of $2,488.52. This firm fixed-price delivery order represents a non-set-aside competitive award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 3, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp leverages this comprehensive IDC to supply a wide range of pharmaceutical products and medical supplies to military and veteran healthcare systems. This particular delivery order for dextroamphetamine reflects the company's role in supporting the Defense Health Agency and other government healthcare systems through the DLA's Medical Supply Chain. The contract demonstrates the contractor's capability to fulfill competitive federal procurement requirements for controlled pharmaceutical substances in support of military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 6/2/25 |